SCHEMBL845341

SCHEMBL845341

Cn1cncc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3cncn3C)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
RHOC P08134 1/20 0.42
RHOA P61586 1/20 0.42
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 3/20 0.41
HTT P42858 2/20 0.41
MAPK1 P28482 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
EP300 Q09472 1/20 0.41
CREBBP Q92793 1/20 0.41
KCNH2 Q12809 1/20 0.41
MAPT P10636 1/20 0.41
PREP P48147 1/20 0.40
TRPV1 Q8NER1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845282 0.83 CYP2C9 (0.47) CYP2C9CYP2C19RHOCRHOANPC1
SCHEMBL844934 0.79 RHOC (0.51) CYP2C9CYP2C19RHOCRHOANPC1
SCHEMBL845176 0.79 CYP2C9 (0.43) CYP2C9CYP2C19RHOCRHOANPC1
SCHEMBL845030 0.79 ALDH1A1 (0.49) CYP2C9CYP2C19NPC1ALDH1A1HTT
SCHEMBL845405 0.79 TRPV1 (0.46) CYP2C9CYP2C19RHOCRHOANPC1
SCHEMBL845338 0.78 RHOC (0.48) CYP2C9CYP2C19RHOCRHOANPC1
SCHEMBL845297 0.78 RHOC (0.48) CYP2C9CYP2C19RHOCRHOANPC1
SCHEMBL873200 0.78 RHOC (0.48) CYP2C9CYP2C19RHOCRHOANPC1
SCHEMBL844890 0.78 KCNH2 (0.51) CYP2C9CYP2C19NPC1ALDH1A1HTT
SCHEMBL845774 0.78 CYP2C19 (0.49) CYP2C9CYP2C19NPC1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed